Fitzgerald Kevin Joseph
Officer at ALNY
- Sold, on record
- $19.7M
- Dollars the filings state
- Form 4 sales
- 13
- Latest Mar 5, 2026
- Form 144 notices
- 10
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ALNYALNYLAM PHARMACEUTICALS, INC.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice ALNYNoticeJan 13, 2026 2026
Filed to sell 2,290 shares ($845k)
Fitzgerald Kevin Joseph, Officer
10b5-1 plan0.9x usual sizeFiling
- 2 Form 4 sale ALNYRoutineJan 13, 2026 same day
Sold 3,800 shares at $367.37 ($1.4M)
Fitzgerald Kevin Joseph, CSO & EVP, Head of Research
10b5-1 planSold 15.2% of holdings ($9.2M position)21,264 shares left1.6x usual sizeFollows a Form 144Filing
- 3 Form 4 sale ALNYRoutineFeb 17, 2026 +35 days
Sold 4,000 shares at $321.24 ($1.3M)
Fitzgerald Kevin Joseph, CSO & EVP, Head of Research
10b5-1 planSold 15.8% of holdings ($8.1M position)21,264 shares left1.5x usual sizeFollows a Form 144Filing
- 4 Form 144 notice ALNYNoticeFeb 17, 2026 same day
Filed to sell 2,041 shares ($678k)
Fitzgerald Kevin Joseph, Officer
10b5-1 plan0.8x usual sizeFiling
- 5 Form 144 notice ALNYNoticeMar 3, 2026 +14 days
Filed to sell 1,652 shares ($531k)
Fitzgerald Kevin Joseph, Officer
10b5-1 plan0.6x usual sizeFiling
- 6 Form 4 sale ALNYRoutineMar 3, 2026 same day
Sold 3,250 shares at $323.62 ($1.1M)
Fitzgerald Kevin Joseph, CSO & EVP, Head of Research
10b5-1 planSold 12.9% of holdings ($8.1M position)21,860 shares left1.2x usual sizeFollows a Form 144Filing
- 7 Form 144 notice ALNYNoticeMar 5, 2026 +2 days
Filed to sell 658 shares ($213k)
Fitzgerald Kevin Joseph, Officer
10b5-1 plan0.2x usual sizeFiling
- 8 Form 4 sale ALNYRoutineMar 5, 2026 same day
Sold 1,291 shares at $323.54 ($418k)
Fitzgerald Kevin Joseph, CSO & EVP, Head of Research
10b5-1 planSold 5.9% of holdings ($7.1M position)20,569 shares left0.4x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (23)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Mar 6, 2026 | ALNY | CSO & EVP, Head of Research | Form 4 sale | 1,291 | $418k | 5.9% | Routine | SEC |
| Mar 5, 2026 | Mar 5, 2026 | ALNY | Officer | Form 144 notice | 658 | $213k | Notice | SEC | |
| Mar 3, 2026 | Mar 4, 2026 | ALNY | CSO & EVP, Head of Research | Form 4 sale | 3,250 | $1.1M | 12.9% | Routine | SEC |
| Mar 3, 2026 | Mar 3, 2026 | ALNY | Officer | Form 144 notice | 1,652 | $531k | Notice | SEC | |
| Feb 17, 2026 | Feb 17, 2026 | ALNY | Officer | Form 144 notice | 2,041 | $678k | Notice | SEC | |
| Feb 17, 2026 | Feb 17, 2026 | ALNY | CSO & EVP, Head of Research | Form 4 sale | 4,000 | $1.3M | 15.8% | Routine | SEC |
| Jan 13, 2026 | Jan 14, 2026 | ALNY | CSO & EVP, Head of Research | Form 4 sale | 3,800 | $1.4M | 15.2% | Routine | SEC |
| Jan 13, 2026 | Jan 13, 2026 | ALNY | Officer | Form 144 notice | 2,290 | $845k | Notice | SEC | |
| Nov 17, 2025 | Nov 19, 2025 | ALNY | CSO & EVP, Head of Research | Form 4 sale | 12,128 | $5.5M | 36.3% | Unusual | SEC |
| Nov 17, 2025 | Nov 17, 2025 | ALNY | Officer | Form 144 notice | 12,128 | $5.4M | Notice | SEC | |
| Oct 2, 2025 | Oct 3, 2025 | ALNY | CSO & EVP, Head of Research | Form 4 sale | 2,441 | $1.1M | 8.8% | No plan | SEC |
| Aug 18, 2025 | Aug 19, 2025 | ALNY | CSO & EVP, Head of Research | Form 4 sale | 1,396 | $633k | 5.8% | No plan | SEC |
| Mar 4, 2025 | Mar 5, 2025 | ALNY | CSO & EVP, Head of Research | Form 4 sale | 2,755 | $669k | 16.9% | Routine | SEC |
| Mar 4, 2025 | Mar 4, 2025 | ALNY | Officer | Form 144 notice | 844 | $203k | Notice | SEC | |
| Mar 3, 2025 | Mar 3, 2025 | ALNY | Officer | Form 144 notice | 1,171 | $288k | Notice | SEC | |
| Feb 28, 2025 | Mar 3, 2025 | ALNY | CSO & EVP, Head of Research | Form 4 sale | 496 | $120k | 3.9% | No plan | SEC |
| Feb 18, 2025 | Feb 18, 2025 | ALNY | Officer | Form 144 notice | 1,440 | $370k | Notice | SEC | |
| Feb 18, 2025 | Feb 18, 2025 | ALNY | CSO & EVP, Head of Research | Form 4 sale | 2,103 | $531k | 14.0% | Routine | SEC |
| Nov 27, 2024 | Nov 27, 2024 | ALNY | CSO & EVP, Head of Research | Form 4 sale | 3,000 | $755k | 18.9% | Routine | SEC |
| Nov 27, 2024 | Nov 27, 2024 | ALNY | Officer | Form 144 notice | 1,531 | $389k | Notice | SEC | |
| Aug 12, 2024 | Aug 14, 2024 | ALNY | CSO & EVP, Head of Research | Form 4 sale | 22,025 | $6M | 63.1% | Routine | SEC |
| Aug 12, 2024 | Aug 12, 2024 | ALNY | Officer | Form 144 notice | 22,025 | $5.9M | Notice | SEC | |
| Jun 25, 2024 | Jun 26, 2024 | ALNY | CSO & EVP, Head of Research | Form 4 sale | 1,198 | $277k | 7.8% | No plan | SEC |